Rosaria Bufalino
- Oncology top 1%
- Immunology top 5%
- Cancer Research top 2%
- Molecular Biology top 10%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Natale CascinelliMartín C. MihmStefano ZurridaPaola ColliniSalvatore AndreolaAlberto MorabitoSylvie MénardFranco Rilke
- Topics
- HER2/EGFR in Cancer Research (16 papers)Breast Cancer Treatment Studies (13 papers)Cutaneous Melanoma Detection and Management (12 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Rosaria Bufalino
57 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 2.3k
- Immunology 910
- Cancer Research 890
- Molecular Biology 713
- Pathology and Forensic Medicine 625
Countries citing papers authored by Rosaria Bufalino
This map shows the geographic impact of Rosaria Bufalino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosaria Bufalino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosaria Bufalino more than expected).
Fields of papers citing papers by Rosaria Bufalino
This network shows the impact of papers produced by Rosaria Bufalino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosaria Bufalino. The network helps show where Rosaria Bufalino may publish in the future.
Co-authorship network of co-authors of Rosaria Bufalino
This figure shows the co-authorship network connecting the top 25 collaborators of Rosaria Bufalino. A scholar is included among the top collaborators of Rosaria Bufalino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosaria Bufalino. Rosaria Bufalino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 41 | |
| 3 | 10 | |
| 4 | HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. | 73 |
| 5 | 44 | |
| 6 | 27 | |
| 7 | 87 | |
| 8 | 11 | |
| 9 | 94 | |
| 10 | 4 | |
| 11 | Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanomabreakdown → | 867 |
| 12 | 16 | |
| 13 | 26 | |
| 14 | 124 | |
| 15 | 85 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 212 | |
| 19 | 51 | |
| 20 | 28 |
About Rosaria Bufalino
Rosaria Bufalino is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 58 papers that have together received 3.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (13 papers) and Cutaneous Melanoma Detection and Management (12 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (890 citations) and Immunology (910 citations). Rosaria Bufalino has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Natale Cascinelli, Martín C. Mihm, Stefano Zurrida, Paola Collini, Salvatore Andreola, Alberto Morabito, Sylvie Ménard, Franco Rilke, N. Cascinelli and Maria Teresa Baldini. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.